Free Trial

Motus GI (MOTS) Competitors

Motus GI logo
$0.0008 0.00 (0.00%)
(As of 11/20/2024 ET)

MOTS vs. VRAYQ, AHPI, NMRD, BRSH, DRTSW, ANZUW, BBLGW, BRSHW, GMVDW, and HSCSW

Should you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry.

Motus GI vs.

Motus GI (NASDAQ:MOTS) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

Motus GI received 163 more outperform votes than ViewRay when rated by MarketBeat users.

CompanyUnderperformOutperform
Motus GIOutperform Votes
163
65.73%
Underperform Votes
85
34.27%
ViewRayN/AN/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
ViewRay Neutral

20.1% of Motus GI shares are held by institutional investors. Comparatively, 15.5% of ViewRay shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Comparatively, 2.5% of ViewRay shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Motus GI has higher earnings, but lower revenue than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$320K0.01-$12.87M-$15.640.00
ViewRay$102.21M0.00-$107.33MN/AN/A

Motus GI has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Comparatively, ViewRay has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500.

ViewRay has a net margin of 0.00% compared to Motus GI's net margin of -3,239.75%. ViewRay's return on equity of 0.00% beat Motus GI's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GI-3,239.75% -1,731.08% -115.99%
ViewRay N/A N/A N/A

Summary

ViewRay beats Motus GI on 5 of the 9 factors compared between the two stocks.

Get Motus GI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

MetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$5,000.00$4.42B$5.06B$8.82B
Dividend YieldN/A41.17%5.18%4.07%
P/E Ratio0.0024.81126.3117.81
Price / Sales0.0147.031,178.7474.57
Price / CashN/A51.8733.8632.53
Price / Book0.004.974.684.68
Net Income-$12.87M$13.76M$119.54M$226.08M
7 Day PerformanceN/A-1.08%-1.83%-1.04%
1 Month PerformanceN/A0.58%-3.60%1.04%
1 Year PerformanceN/A50.91%31.91%26.28%

Motus GI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOTS
Motus GI
N/A$0.00
flat
N/A-100.0%$5,000.00$320,000.000.0030
VRAYQ
ViewRay
N/AN/AN/AN/A$20,000.00$102.21M0.00300
AHPI
Allied Healthcare Products
N/AN/AN/AN/A$16,000.00$27.05M0.00150
NMRD
Nemaura Medical
N/AN/AN/AN/A$10,000.00$80,000.000.0040
BRSH
Bruush Oral Care
N/A$0.00
flat
N/A-99.7%$1,000.00$2.92M0.0011
DRTSW
Alpha Tau Medical
N/A$0.22
+29.8%
N/A-15.4%$0.00N/A0.0080News Coverage
Gap Up
ANZUW
Anzu Special Acquisition Corp I
N/A$0.06
flat
N/AN/A$0.00N/A0.002
BBLGW
Bone Biologics
N/A$28.49
flat
N/AN/A$0.00N/A0.002
BRSHW
Bruush Oral Care
N/A$0.01
flat
N/AN/A$0.00$2.92M0.0011
GMVDW
G Medical Innovations
N/A$0.02
flat
N/AN/A$0.00$4.42M0.0072
HSCSW
Heart Test Laboratories
N/A$0.03
flat
N/AN/A$0.00$18,600.000.0010

Related Companies and Tools


This page (NASDAQ:MOTS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners